Xcout Intel
QurieGen competitors & alternatives
The 12 closest competitors and alternatives to QurieGen among drug discovery companies — ranked by similarity to what QurieGen actually does, not by market-cap band.
Subscribe to see QurieGen’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About QurieGen
QurieGen is a precision medicine company headquartered in Nijmegen, Netherlands, that uses single-cell AI to transform drug development and create treatments more efficiently.
QurieGen at a glance
QurieGen is a drug discovery company headquartered in Netherlands. Its most recent funding round, Pre-Seed, raised $2.4M in April 2025. Xcout tracks 2 named people at QurieGen, including Kinga Matula (CEO and co-founder).
QurieGen leadership
- Kinga MatulaCEO and co-founder
- Maciej JarzabCOO and co-founder
QurieGen funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-Seed | $2.4M | 11 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 QurieGen competitors
Ranked by semantic similarity — how close each company is to QurieGen by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar drug discovery company
Cassidy Bio is an AI-first biotechnology company founded in 2024 and based in Israel that is developing a programmable platform for gene editing. The company utilizes a genomic foundation model powered by artificial intelligence to design safer and more scalable gene editing therapies across various guides, editors, and delivery contexts.
Similar drug discovery company
Cellyrix Therapeutics is an Israeli biotechnology company that develops targeted cancer therapies by leveraging single-cell RNA sequencing and artificial intelligence. The firm operates as an oncology-focused drug discovery venture headquartered in Rehovot, Israel.
Similar drug discovery company
RyboDyn is a biotechnology company that uses its proprietary RyboCypher platform, combining RNA sequencing and AI, to decode the dark proteome and identify hidden cancer targets. The company develops next-generation, antibody-based immunotherapies designed to address critical unmet needs in cancer treatment.
Similar drug discovery company
Gero is a biotechnology company headquartered in Singapore with a U.S. subsidiary, combining physics, biology, and artificial intelligence to decode human biology and develop life-changing medicines.
Similar drug discovery company
Coding Bio is an Oxford-based biotechnology company that combines a high-throughput wet lab and machine learning platform to screen, build, and deliver fully-assembled modular therapies like CARs and BiTEs.
Similar drug discovery company
Curreio is a biotechnology company founded in 2019 and headquartered in Japan. It operates as a contract research organization (CRO) providing drug discovery and development support services utilizing high-resolution structural analysis with cryo-electron microscopy technology.
Similar drug discovery company
CubaseBio is a spatial biology company headquartered in Stockholm, Sweden, founded to build innovative tools that reveal biological structures in three dimensions.
Decision/Risk
Moonlight AI is a Swiss startup created to democratize access to essential genomic information for therapy decision-making in the era of personalized medicine.
Deep Tech
AQEMIA is a French technology company that uses quantum-inspired algorithms and artificial intelligence for drug discovery. It develops therapeutic candidates and works with pharmaceutical and biotechnology companies to accelerate the design of new medicines.
Agtech
Quercus Biosolutions is a biotechnology company headquartered in Saint Louis, Missouri, that uses generative artificial intelligence to develop biology-based crop protection solutions.
Similar drug discovery company
Coultreon Biopharma is a clinical-stage biotechnology company headquartered in Leuven, Belgium, focused on developing next-generation precision medicines for immunology and autoimmune diseases. Backed by substantial venture funding, the company advances innovative therapies.
Biopharmaceuticals
Acerta Pharma, a member of the AstraZeneca group located in Oss, Netherlands, focuses on the discovery, development, and delivery of targeted novel transformational medicines.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of QurieGen and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for QurieGenand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →